Prevent concomitant usage of tucatinib with CYP3A substrates, where negligible focus adjustments could result in serious or life-threatening toxicities. If unavoidable, reduce CYP3A substrate dose In line with solution labeling.posaconazole will improve the amount or effect of modafinil by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Us

Article Under Review